Literature DB >> 2454761

Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart.

I Komuro1, M Kurabayashi, F Takaku, Y Yazaki.   

Abstract

Proto-oncogenes have been revealed to participate in normal cell proliferation as well as in cell transformation. Since cardiac myocytes are terminally differentiated, they cannot divide except in the fetal period. To determine the role of cellular oncogenes in the growth of the heart, the expression pattern of eight cellular oncogenes during the developmental stage and pressure-overloaded hypertrophy of the rat hearts were examined in vivo. Northern blot analysis was performed with eight oncogene probes (myc, fos, Ha-ras, src, erbA, erbB, sis, myb). Pressure overload increased the levels of cellular (c-) fos, c-myc, and c-Ha-ras. An increase of c-fos and c-myc was detected at 30 minutes and 2 hours, respectively; the levels peaked at 8 hours, and they returned to baseline by 48 hours after aortic constriction. However, the level of c-Ha-ras showed a gradual increase. During the course of development, the expression of c-myc was detectable only in the embryonic stage, whereas the expression of c-fos was not detected in the fetal period, was increased after birth, and peaked in 200-day-old adults. The expression of c-Ha-ras was almost the same throughout the development. Cellular oncogenes were expressed in the heart in response to pressure overload and in a stage-specific manner. These results suggest that cellular oncogenes may participate in the normal developmental process and hypertrophy of hearts and that the cellular hypertrophy induced by pressure overload may share a similar mechanistic pathway with cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454761     DOI: 10.1161/01.res.62.6.1075

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  39 in total

1.  Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload.

Authors:  T Senbonmatsu; S Ichihara; E Price; F A Gaffney; T Inagami
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Regulation of protein turnover in skeletal and cardiac muscle.

Authors:  P H Sugden; S J Fuller
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

Review 3.  Recombinant DNA and surgery.

Authors:  J M Brown; A H Harken; J B Sharefkin
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

4.  Molecular aspects of mechanical stress-induced cardiac hypertrophy.

Authors:  T Yamazaki; I Komuro; Y Yazaki
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

Review 5.  The renin-angiotensin system and cardiac hypertrophy.

Authors:  T Yamazaki; I Komuro; I Shiojima; Y Yazaki
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

6.  A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program.

Authors:  M N Sack; D L Disch; H A Rockman; D P Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

7.  Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure.

Authors:  Ning Hou; Bo Ye; Xiang Li; Kenneth B Margulies; Haodong Xu; Xuejun Wang; Faqian Li
Journal:  Circ Heart Fail       Date:  2016-06-14       Impact factor: 8.790

8.  Immediate-early gene induction and MAP kinase activation during recovery from metabolic inhibition in cultured cardiac myocytes.

Authors:  A Yao; T Takahashi; T Aoyagi; K Kinugawa; O Kohmoto; S Sugiura; T Serizawa
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Degeneration of skeletal and cardiac muscles in c-myb transgenic mice.

Authors:  Y Furuta; S Aizawa; Y Suda; Y Ikawa; H Nakasgoshi; Y Nishina; S Ishii
Journal:  Transgenic Res       Date:  1993-07       Impact factor: 2.788

10.  Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure.

Authors:  Hyoung-gon Lee; Qun Chen; Julie A Wolfram; Sandy L Richardson; Anna Liner; Sandra L Siedlak; Xiongwei Zhu; Nicholas P Ziats; Hisashi Fujioka; Dean W Felsher; Rudy J Castellani; Maria L Valencik; John A McDonald; Brian D Hoit; Edward J Lesnefsky; Mark A Smith
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.